RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RUSSO D
Collezione AOU Novara

Items : 6

The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2024 May;24(5):323-331. doi: 10.1016/j.clml.2024.01.008. Epub 2024 Jan 2

2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Novara

Roccaro AM; Pellizzeri S; Butturini G; Bernardi S; Farina M; Defina M; Russo Rossi A; Russo S; Romano A; Tiribelli M; De Gobbi M; Coppi MR; Corsetti MT; Sancetta R; Rosti G; Lemoli RM; Castagnetti F; Lunghi F; Crugnola M; Ferrari ML; D'Adda M; Lunghi M; Stagno F; Binotto G; Abruzzese E; Bonifacio M; Russo D; Bucelli C; Iurlo A; et alii...

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years. in The Journal of dermatological treatment / J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602.

2023
AOU Città della Salute di Torino
AOU Novara

Picone V; di Vico F; Chiodini P; Vallone Y; Fargnoli MC; Esposito M; Satta R; Dragoni F; Termine S; Pezzolo E; Gruber M; Berti SF; Veronese F; Zangari P; Ferreli C; Patella V; Peduto T; Moschese V; Russo D; Di Pillo S; Palermo A; Marseglia GL; Leonardi S; Licari A; Provenzano E; Amoruso FG; Guerriero C; De Simone C; Chiricozzi A; et alii...

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study. in Cancer medicine / Cancer Med. 2021 Mar;10(5):1726-1737. doi: 10.1002/cam4.3778. Epub 2021 Feb 16.

2021
AOU Alessandria
AOU San Luigi di Orbassano
AOU Novara

De Vivo A; Baccarani M; Roccaro AM; Polverelli N; Bernardi S; Farina M; Bocchia M; Gandolfi L; Aprile L; Russo S; Russo Rossi A; Tiribelli M; Romano A; Rege Cambrin G; Coppi MR; Corsetti MT; Sancetta R; Lemoli RM; Rosti G; Castagnetti F; Lunghi F; Ferrari ML; Crugnola M; Lunghi M; Binotto G; D'Adda M; Stagno F; Abruzzese E; Bonifacio M; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation. in Cancer medicine / Cancer Med. 2019 May;8(5):2041-2055. doi: 10.1002/cam4.2087. Epub 2019 Apr 4.

2019
AOU Novara

Bernardi S; Malagola M; Zanaglio C; Polverelli N; Dereli Eke E; D'Adda M; Farina M; Bucelli C; Scaffidi L; Toffoletti E; Deambrogi C; Stagno F; Bergamaschi M; Franceschini L; Abruzzese E; Divona MD; Gobbi M; Di Raimondo F; Gaidano G; Tiribelli M; Bonifacio M; Cattaneo C; Iurlo A; Russo D;

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Soverini S; Vigneri P; Rosti G; Russo D; Saglio G; Castagnetti F; Pane F; Breccia M; Bonifacio M; Tomassetti S; Trabacchi E; Spadano R; Tiribelli M; Stagno F; Sancetta R; Sica S; Rege-Cambrin G; Rupoli S; Salvucci M; Rapezzi D; Pregno P; Palmieri F; Musolino C; Miggiano MC; Montefusco E; Melpignano A; Martino B; Marasca R; Lunghi M; et alii...